Privigen Market Report 2026

Privigen Market Overview

• The Privigen market growth in the historic period has been driven by expansion of plasma donation networks, rising diagnosis of primary immunodeficiency disorders • Market expansion is supported by increasing demand for long-term immunotherapy treatments, expansion of homecare infusion services • Growth Driver: Rising Immunodeficiency Drives Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Privigen Market?

Privigen is an intravenous immunoglobulin (IVIg) treatment made from human plasma. It is primarily used to manage conditions related to weakened immune systems, such as primary immunodeficiency (PI), chronic inflammatory demyelinating polyneuropathy (CIDP), and idiopathic thrombocytopenic purpura (ITP). Privigen helps boost immunity by providing antibodies that support the body in fighting infections or regulating immune responses. The main formulation types of privigen are liquid (10% solution) and lyophilized. Privigen liquid (10% solution) is a sterile intravenous immunoglobulin (IVIg) preparation used to treat immunodeficiency disorders and autoimmune conditions by providing essential antibodies. The indications are primary immunodeficiency (PI), chronic inflammatory demyelinating polyneuropathy (CIDP), immune thrombocytopenic purpura (ITP), guillain-barré syndrome, and others and it is used by various end users such as hospitals, clinics, and home care settings.

What Is The Privigen Market Growth Forecast?

The growth in the forecast period can be attributed to increasing demand for long-term immunotherapy treatments, expansion of homecare infusion services, rising investment in plasma supply security, growing prevalence of autoimmune disorders, improved manufacturing efficiency for ivig products. Major trends in the forecast period include increasing demand for immunoglobulin therapies, expansion of plasma collection infrastructure, rising use of home-based ivig administration, improved plasma fractionation technologies, growing focus on chronic immune disorders.

Global Privigen Market Segmentation

1) By Formulation: Liquid (10% solution), Lyophilized 2) By Indication: Primary Immunodeficiency (PI), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Immune Thrombocytopenic Purpura (ITP), Guillain-Barré Syndrome, Other Autoimmune Disorders 3) By End Users: Hospitals, Clinics, Homecare settings

What Are The Drivers Of The Privigen Market?

The increase in the prevalence of immunodeficiency disorders is expected to propel the privigen market going forward. Immunodeficiency disorders are conditions that impair the immune system's ability to defend the body against infections and diseases. The prevalence of immunodeficiency disorders is rising due to factors such as increasing awareness and improved diagnostic capabilities, longer survival rates of individuals with primary immunodeficiencies, growing use of immunosuppressive therapies, and higher rates of chronic diseases. Privigen, an intravenous immunoglobulin (IVIG), is used to treat immunodeficiency disorders by boosting antibody levels, helping patients fight infections and maintain immune system function effectively. For instance, in May 2023, according to the University of Oxford, the 19 most common autoimmune diseases affected 3-9% of the population of the United Kingdom in 2022, which reached 10% of the population in 2023. Therefore, the rise in the prevalence of immunodeficiency disorders drives the privigen industry. The rise in favorable government initiatives is expected to propel the privigen market going forward. Government initiatives in healthcare are programs, policies, or actions implemented by governments to improve public health, enhance access to medical services, and promote the well-being of their populations. The favorable government initiatives are rising due to factors such as increasing demand for affordable and accessible medical services, the need to address aging populations and chronic diseases, and advancements in medical technology. Government initiatives supporting immunodeficiency treatments help improve access to therapies such as privigen, ensuring affordable and timely care for patients through funding and healthcare programs. For instance, in February 2023, according to the National Institute for Health and Care Research, a UK-based funding agency, the funding announced for the NIHR BioResource for the research using genetic information to find new tests and treatments for rare diseases, including immunodeficiencies and hemophilia, in 2022 was $50.89 million, which in 2023 reached $1005.17 million. Therefore, the rise in favorable government initiatives drives the privigen industry. The rise in healthcare expenditure is expected to propel the privigen market going forward. Healthcare expenditure refers to the total amount of financial resources spent on medical services, healthcare infrastructure, pharmaceuticals, and healthcare-related activities. Healthcare expenditure is rising due to factors such as higher operational costs in healthcare facilities, increasing prevalence of chronic and lifestyle-related diseases, rise in prevalence of genetic disorders, advances in medical technology, and greater access to healthcare services. Increased healthcare expenditure facilitates better access to therapies such as privigen for immunodeficiency disorders, improving treatment availability, patient outcomes, and overall healthcare infrastructure. For instance, in May 2024, according to a report published by the Office for National Statistics, a UK-based government agency, total healthcare expenditure rose by 5.6% in nominal terms from 2022 to 2023, compared to a growth rate of 0.9% in 2022. Additionally, total long-term health and social care expenditure increased by 2.8% in real terms in 2022. Therefore, the increase in healthcare expenditure drives the privigen industry.

Key Players In The Global Privigen Market

Major companies operating in the privigen market are CSL Behring AG

Regional Insights

North America was the largest region in the privigen market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Privigen Market?

The privigen market consists of sales of privigen liquid for primary immunodeficiency, liquid for chronic immune thrombocytopenic purpura, and liquid for chronic inflammatory demyelinating polyneuropathy. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Privigen Market Report 2026?

The privigen market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the privigen industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.